Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10037679HBVENSG00000106804.10protein_codingC5NoNo727P01031
TVIS10031602HBVENSG00000106804.10protein_codingC5NoNo727P01031
TVIS10025527HBVENSG00000106804.10protein_codingC5NoNo727P01031
TVIS10024806HBVENSG00000106804.10protein_codingC5NoNo727P01031
TVIS10049406HBVENSG00000106804.10protein_codingC5NoNo727P01031
TVIS10049407HBVENSG00000106804.10protein_codingC5NoNo727P01031
TVIS30000179HIVENSG00000106804.10protein_codingC5NoNo727P01031
TVIS30077807HIVENSG00000106804.10protein_codingC5NoNo727P01031
TVIS30020975HIVENSG00000106804.10protein_codingC5NoNo727P01031
TVIS20031120HPVENSG00000106804.10protein_codingC5NoNo727P01031
TCGA Plot Options
Drug Information
GeneC5
DrugBank IDDB00028
Drug NameHuman immunoglobulin G
Target IDBE0000855
UniProt IDP01031
Regulation Typebinder
PubMed IDs20441428; 17351760; 17911465
CitationsBaerenwaldt A, Biburger M, Nimmerjahn F: Mechanisms of action of intravenous immunoglobulins. Expert Rev Clin Immunol. 2010 May;6(3):425-34. doi: 10.1586/eci.10.9.@@Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, Kazatchkine MD, Lacroix-Desmazes S, Bayry J, Kaveri SV: Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol. 2007 May;27(3):233-45. Epub 2007 Mar 11.@@Siberil S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayry J, Kaveri SV: Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Ann N Y Acad Sci. 2007 Sep;1110:497-506.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA164754884
ChEMBL